In our case-series, 38% of tumors showed a gain at 20q chromosome arm, where multiple candidate oncogenes associated with increased proliferative activity, reduced survival and progression of colorectal cancer (e.g. ZNF217, CYP24 and AURKA), are mapped [12,33]. This evidence concerns the gene ZNF217 and colorectal cancer.